Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer
Motahareh Mortazavi, Fatemeh Moosavi, Miriam Martini, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 176, pp. 103749-103749
Closed Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects
Silvius Stanciu, Florentina Ioniţă‐Radu, Constantin Ştefani, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10132-10132
Open Access | Times Cited: 71
Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review
Tohada M. AL‐Noshokaty, Abdallah Mansour, Rehab Abdelhamid, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154438-154438
Closed Access | Times Cited: 50
Phosphoinositide 3-kinase (PI3K) classes: From cell signaling to endocytic recycling and autophagy
Ava Safaroghli‐Azar, Mohammad‐Javad Sanaei, Atieh Pourbagheri‐Sigaroodi, et al.
European Journal of Pharmacology (2023) Vol. 953, pp. 175827-175827
Closed Access | Times Cited: 21
Molecular Mechanisms of Cachexia: A Review
Mahdi Neshan, Diamantis I. Tsilimigras, Xu Han, et al.
Cells (2024) Vol. 13, Iss. 3, pp. 252-252
Open Access | Times Cited: 10
Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11
Zixi Wang, Huaiyuan Zong, Weiwei Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 10
Molecular Targeting of the Phosphoinositide-3-Protein Kinase (PI3K) Pathway across Various Cancers
Khine Shan, Amalia Bonano-Rios, Nyein Wint Yee Theik, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 1973-1973
Open Access | Times Cited: 8
Targeting the RAS upstream and downstream signaling pathway for Cancer treatment
Md. Arafat Hossain
European Journal of Pharmacology (2024) Vol. 979, pp. 176727-176727
Closed Access | Times Cited: 7
Regulation of pancreatic cancer cells by suppressing KIN17 through the PI3K/AKT/mTOR signaling pathway
Qiuyan Li, Yuxia Yang, Xiaocong Lin, et al.
Oncology Reports (2025) Vol. 53, Iss. 2
Closed Access
Tirzepatide and Cancer Risk in Individuals with and without Diabetes: A Systematic Review and Meta-Analysis
A B Kamrul-Hasan, Muhammad Shah Alam, Deep Dutta, et al.
Endocrinology and Metabolism (2025)
Open Access
Targeting KRAS in Pancreatic Ductal Adenocarcinoma: The Long Road to Cure
Victor Hugo Fonseca de Jesus, Maria Cecília Mathias-Machado, João Paulo Fogacci de Farias, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5015-5015
Open Access | Times Cited: 17
The circadian clock is disrupted in pancreatic cancer
Patrick B. Schwartz, Manabu Nukaya, Mark E. Berres, et al.
PLoS Genetics (2023) Vol. 19, Iss. 6, pp. e1010770-e1010770
Open Access | Times Cited: 16
Therapeutic Approaches in Pancreatic Cancer: Recent Updates
Lokender Kumar, Sanjay Kumar, Sandeep Kumar, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1611-1611
Open Access | Times Cited: 14
DHCR7 promotes lymph node metastasis in cervical cancer through cholesterol reprogramming-mediated activation of the KANK4/PI3K/AKT axis and VEGF-C secretion
Xinyu Mei, Jinfeng Xiong, Jian Liu, et al.
Cancer Letters (2024) Vol. 584, pp. 216609-216609
Open Access | Times Cited: 5
Precision treatment of pancreatic ductal adenocarcinoma
Hongyun Wei, He Ren
Cancer Letters (2024) Vol. 585, pp. 216636-216636
Closed Access | Times Cited: 5
Fibroblasts in the Aged Pancreas Drive Pancreatic Cancer Progression
Daniel J. Zabransky, Yash Chhabra, Mitchell E. Fane, et al.
Cancer Research (2024) Vol. 84, Iss. 8, pp. 1221-1236
Closed Access | Times Cited: 4
The trend toward more target therapy in pancreatic ductal adenocarcinoma
Chiara Deiana, Margherita Agostini, Giovanni Brandi, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 7, pp. 525-565
Open Access | Times Cited: 4
Clinical and Preclinical Targeting of Oncogenic Pathways in PDAC: Targeted Therapeutic Approaches for the Deadliest Cancer
Diego J. Jiménez, Aadil Javed, Teresa Rubio‐Tomás, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2860-2860
Open Access | Times Cited: 3
PABPC1 silencing inhibits pancreatic cancer cell proliferation and EMT, and induces apoptosis via PI3K/AKT pathway
Changren Zhu, Cuimei Wang, Xiaodong Wang, et al.
Cytotechnology (2024) Vol. 76, Iss. 3, pp. 351-361
Closed Access | Times Cited: 3
Transforming Growth Factor-Beta Signaling in Cancer-Induced Cachexia: From Molecular Pathways to the Clinics
Rita Balsano, Zita Kruize, Martina Lunardi, et al.
Cells (2022) Vol. 11, Iss. 17, pp. 2671-2671
Open Access | Times Cited: 19
DHCR7 promotes tumorigenesis via activating PI3K/AKT/mTOR signalling pathway in bladder cancer
Yan Li, Yongying Zhou, Mingliu Huang, et al.
Cellular Signalling (2022) Vol. 102, pp. 110553-110553
Closed Access | Times Cited: 15
Epigenetic upregulation of MNAT1 by SMYD2 is linked to PI3K/AKT activation and tumorigenesis of pancreatic adenocarcinoma.
Zhen Xu, Yan Liu, Zhi Pan, et al.
PubMed (2024) Vol. 39, Iss. 2, pp. 263-277
Closed Access | Times Cited: 2
Clinical and Preclinical Targeting of Oncogenic Pathways in PDAC: Targeted Therapeutic Approaches for the Deadliest Cancer
Diego J Jiménez, Aadil Javed, Teresa Rubio‐Tomás, et al.
(2024)
Open Access | Times Cited: 2
Single‐cell RNA sequencing reveals the mechanism of PI3K/AKT/mTOR signaling pathway activation in lung adenocarcinoma by KRAS mutation
Long Xu, Renquan Ding, Shuxi Song, et al.
The Journal of Gene Medicine (2024) Vol. 26, Iss. 1
Closed Access | Times Cited: 2
HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1/PI3K/AKT signaling pathway
Junqi Wang, Kehu Yang, Xin Yang, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 7, pp. 1275-1287
Closed Access | Times Cited: 2
Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: biomarkers and beyond
Marianna Sirico, Flavia Jacobs, Chiara Molinelli, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 200, pp. 104404-104404
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top